View in EDS

Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies.

Saved in:
Bibliographic Details
Title: Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies.
Authors: Servitja S; Hospital del Mar, Hospital del Mar Research Institute Barcelona, Barcelona, Spain. sservitja@hmar.cat.; Universitat Pompeu Fabra, Barcelona, Spain. sservitja@hmar.cat.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. sservitja@hmar.cat.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. sservitja@hmar.cat., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Andrés R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Martín M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Guerrero Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Valencia, Spain., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Miguel Servet, Zaragoza, Spain., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clinic i Provincial, Barcelona, Spain., Margeli M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Germans Trias i Pujol, Badalona, Spain., Álvarez I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastián, Spain., Fernández LA; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Consorci Corporació Sanitària Parc Taulí, Sabadell, Spain., Ponce J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Alicante, Alicante, Spain., Cruz J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Martínez P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain., López-Tarruella S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Amenedo M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, La Coruña, Spain., Blasco A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Gil-Gil M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Catalán de Oncología-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain.
Source: Breast cancer research : BCR [Breast Cancer Res] 2026 May 25; Vol. 28 (1). Date of Electronic Publication: 2026 May 25.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42185928
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Servitja+S%22">Servitja S</searchLink>; Hospital del Mar, Hospital del Mar Research Institute Barcelona, Barcelona, Spain. sservitja@hmar.cat.; Universitat Pompeu Fabra, Barcelona, Spain. sservitja@hmar.cat.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. sservitja@hmar.cat.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. sservitja@hmar.cat.<br /><searchLink fieldCode="AU" term="%22Carrasco+E%22">Carrasco E</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Andrés+R%22">Andrés R</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Lescure+Á%22">Rodríguez-Lescure Á</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain.<br /><searchLink fieldCode="AU" term="%22Martín+M%22">Martín M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ruiz-Borrego+M%22">Ruiz-Borrego M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Guerrero+Á%22">Guerrero Á</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Bermejo+B%22">Bermejo B</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Antón+A%22">Antón A</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Miguel Servet, Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz+M%22">Muñoz M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clinic i Provincial, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Margeli+M%22">Margeli M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Germans Trias i Pujol, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Álvarez+I%22">Álvarez I</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastián, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+LA%22">Fernández LA</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Consorci Corporació Sanitària Parc Taulí, Sabadell, Spain.<br /><searchLink fieldCode="AU" term="%22Ponce+J%22">Ponce J</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Alicante, Alicante, Spain.<br /><searchLink fieldCode="AU" term="%22Cruz+J%22">Cruz J</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez+P%22">Martínez P</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain.<br /><searchLink fieldCode="AU" term="%22López-Tarruella+S%22">López-Tarruella S</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Amenedo+M%22">Amenedo M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, La Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Blasco+A%22">Blasco A</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Polonio+Ó%22">Polonio Ó</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gil-Gil+M%22">Gil-Gil M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Catalán de Oncología-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2026 May 25; Vol. 28 (1). <i>Date of Electronic Publication: </i>2026 May 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42185928
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13058-026-02300-0
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Servitja S
      – PersonEntity:
          Name:
            NameFull: Carrasco E
      – PersonEntity:
          Name:
            NameFull: Andrés R
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Lescure Á
      – PersonEntity:
          Name:
            NameFull: Martín M
      – PersonEntity:
          Name:
            NameFull: Ruiz-Borrego M
      – PersonEntity:
          Name:
            NameFull: Guerrero Á
      – PersonEntity:
          Name:
            NameFull: Bermejo B
      – PersonEntity:
          Name:
            NameFull: Antón A
      – PersonEntity:
          Name:
            NameFull: Muñoz M
      – PersonEntity:
          Name:
            NameFull: Margeli M
      – PersonEntity:
          Name:
            NameFull: Álvarez I
      – PersonEntity:
          Name:
            NameFull: Fernández LA
      – PersonEntity:
          Name:
            NameFull: Ponce J
      – PersonEntity:
          Name:
            NameFull: Cruz J
      – PersonEntity:
          Name:
            NameFull: Martínez P
      – PersonEntity:
          Name:
            NameFull: López-Tarruella S
      – PersonEntity:
          Name:
            NameFull: Amenedo M
      – PersonEntity:
          Name:
            NameFull: Blasco A
      – PersonEntity:
          Name:
            NameFull: Polonio Ó
      – PersonEntity:
          Name:
            NameFull: Gil-Gil M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 05
              Text: 2026 May 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1465-542X
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research : BCR
              Type: main
ResultId 1